Gilead Sciences GILD Valuation Implications of Expanded Kymera Therapeutics Collaboration and Kymeras FDA Fast Track Designation TNDM Tandem posts far narrower Q4 2025 loss than analyst estimates shares slip 252 percent today Should I hold or sell F5 FFIV stock today F5 Posts 195 Percent EPS Beat Tops Street Views Welltower Inc WELL Q1 2026 Earnings Preview Strong TopLine and FFO Growth Expected Amid Favorable Healthcare REIT Tailwinds Is Real Asset RAAQ stock forming higher highs DLO DLocal posts narrow Q4 2025 EPS beat shares gain 338 percent after earnings release JBI Janus falls 405 after Q4 2025 earnings miss as EPS lands 106 below consensus analyst estimates Is Brighthouse BHFAN stock in consolidation Q4 2025 EPS Misses Estimates